Indeed, in vitro PRPF8 silencing reduced the proliferation of different liver cancer cell lines through the modulation of important CDKs34 such as CDK2, reduced the migration capacity, and reduced the colony and tumorsphere formation capacity, all of which are important features related to the control of cancer stem cell viability and cancer progression. Here, CDK2 is linked to liver cancer.